Wordt geladen...
Virtual screening of approved clinic drugs with main protease (3CL(pro)) reveals potential inhibitory effects on SARS-CoV-2
3CL(pro) is the main protease of the novel coronavirus (SARS-CoV-2) responsible for their intracellular duplication. Based on virtual screening technology and molecular dynamics simulation, we found 23 approved clinical drugs such as Viomycin, Capastat, Carfilzomib and Saquinavir, which showed high...
Bewaard in:
| Gepubliceerd in: | J Biomol Struct Dyn |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Taylor & Francis
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7544985/ https://ncbi.nlm.nih.gov/pubmed/32909528 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/07391102.2020.1817786 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|